BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 21654529)

  • 1. A comprehensive approach to fragility fractures.
    Rebolledo BJ; Unnanuntana A; Lane JM
    J Orthop Trauma; 2011 Sep; 25(9):566-73. PubMed ID: 21654529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing osteoporotic fractures in older people.
    McCloskey E
    Practitioner; 2011 Jan; 255(1736):19-22, 2-3. PubMed ID: 21370710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the medical management of osteoporosis.
    Kates SL; Kates OS; Mendelson DA
    Injury; 2007 Sep; 38 Suppl 3():S17-23. PubMed ID: 17723788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for treatment to prevent fragility fractures in postmenopausal women.
    Geusens P
    Best Pract Res Clin Rheumatol; 2009 Dec; 23(6):727-40. PubMed ID: 19945685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis disease management for fragility fracture patients: new understandings based on three years' experience with an osteoporosis care service.
    Harrington JT; Lease J
    Arthritis Rheum; 2007 Dec; 57(8):1502-6. PubMed ID: 18050169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and treatment of postmenopausal osteoporosis.
    Lewiecki EM
    Obstet Gynecol Clin North Am; 2008 Jun; 35(2):301-15, ix. PubMed ID: 18486843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anabolic therapies for osteoporosis.
    Uihlein AV; Leder BZ
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
    Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
    Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture.
    Miller RG
    Geriatrics; 2006 Jan; 61(1):24-30. PubMed ID: 16405361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiresorptive agents, raloxifene, and PHARMAC.
    Gilchrist N
    N Z Med J; 2006 Mar; 119(1230):U1885. PubMed ID: 16532050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G; Ziegler R
    Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal osteoporosis: fracture risk and prevention.
    Kaunitz AM; McClung MR; Feldman RG; Wysocki S
    J Fam Pract; 2009 Nov; 58(11 Suppl Postmenopausal):S1-6. PubMed ID: 19891943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporotic Fracture Program management: who should be in charge? A comparative survey of knowledge in orthopaedic surgeons and internists.
    Sorbi R; Aghamirsalim M
    Orthop Traumatol Surg Res; 2013 Oct; 99(6):723-30. PubMed ID: 23849486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations on the management of fragility fracture risk in women younger than 70 years.
    Palacios S; Christiansen C; Sánchez Borrego R; Gambacciani M; Hadji P; Karsdal M; Lambrinoudaki I; Lello S; O'Beirne B; Romao F; Rozenberg S; Stevenson JC; Ben-Rafael Z
    Gynecol Endocrinol; 2012 Oct; 28(10):770-86. PubMed ID: 22558997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and treatment of bone disease after fragility fracture.
    Gibson MV
    Geriatrics; 2008 Jul; 63(7):21-30. PubMed ID: 18593210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who will benefit from antiresorptive treatment (bisphosphonates)?
    Papapoulos SE
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):965-73. PubMed ID: 16301190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
    Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE
    Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.